Anna Gordon

Anna Gordon is an early career journalist who graduated from Columbia Journalism School in 2021. Her favorite stories are those that explore the complicated economic tradeoffs in healthcare. For her master’s thesis at Columbia, she created a 30-minute podcast exploring the science behind a new groundbreaking cystic fibrosis drug. She also published a freelance story about how the lifesaving drug’s high cost has kept it from being distributed in Canada. Since graduating Columbia, she has worked as a reporter at Chief Investment Officer Magazine where she writes daily stories and features about large institutional investors.